Literature DB >> 17194737

N-procalcitonin: central effects on feeding and energy homeostasis in rats.

Eva Tavares1, Rosario Maldonado, Francisco J Miñano.   

Abstract

Procalcitonin (PCT), the precursor of calcitonin (CT), is a 116-amino-acid peptide, but PCT itself has no known activity. However, although the C cells of the thyroid gland are the dominant source of circulating CT, PCT and its free bioactive amino-terminal fragment (N-PCT) have been localized in adipocytes and neuroendocrine cells as well as in some hypothalamic regions of primary importance in the regulation of feeding and energy balance. These findings together with the coelaboration of N-PCT and CT, and N-PCT's sequence conservation during evolution, suggest that N-PCT has a critical, and as yet undefined, physiological function. We demonstrate here that intracerebroventricular administration of N-PCT significantly decreased food intake and body weight gain for at least 48 h in conscious, freely moving, and unstressed rats fed ad libitum. These effects were accompanied by a transitory increase in body temperature and a decrease in locomotor activity. Moreover, after intracerebroventricular N-PCT administration, Fos protein, a marker of neuronal activation, was found in regions of primary importance in the integration of hormonal signals for energy homeostasis and feeding. In contrast, ip administration of N-PCT did not elicit any anorectic or catabolic effects. Furthermore, PCT was found in key feeding areas such as the arcuate nucleus of free-feeding rats, and its level was significantly reduced after fasting. These results suggest that N-PCT can function as an endogenous ligand for the CT receptor and may act as a catabolic signaling molecule in the central regulation of feeding behavior and energy homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194737     DOI: 10.1210/en.2006-0792

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

Review 1.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

2.  Serum PCT and its Relation to Body Weight Gain in Pulmonary Tuberculosis.

Authors:  K Rohini; Surekha Bhat; P S Srikumar; A Mahesh Kumar
Journal:  Indian J Clin Biochem       Date:  2014-04-18

3.  Procalcitonin is expressed in osteoblasts and limits bone resorption through inhibition of macrophage migration during intermittent PTH treatment.

Authors:  Anke Baranowsky; Denise Jahn; Shan Jiang; Timur Yorgan; Peter Ludewig; Jessika Appelt; Kai K Albrecht; Ellen Otto; Paul Knapstein; Antonia Donat; Jack Winneberger; Lana Rosenthal; Paul Köhli; Cordula Erdmann; Melanie Fuchs; Karl-Heinz Frosch; Serafeim Tsitsilonis; Michael Amling; Thorsten Schinke; Johannes Keller
Journal:  Bone Res       Date:  2022-01-27       Impact factor: 13.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.